The Current Ratio as of December 2025 (TTM) for Mercury Biopharmaceutical Corporation (6932.TWO) is 9.21

According to Mercury Biopharmaceutical Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 9.21. This represents a change of -56.45% compared to the average of 21.16 of the last 4 quarters.

Mercury Biopharmaceutical Corporation (6932.TWO) Historical Current Ratio (quarterly & annually)

How has 6932.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Mercury Biopharmaceutical Corporation over the last ten years is 13.10. The current 9.21 Current Ratio has changed 6.93% with respect to the historical average. Over the past ten years (40 quarters), 6932.TWO's Current Ratio was at its highest in in the June 2023 quarter at 75.37. The Current Ratio was at its lowest in in the June 2019 quarter at 0.

Mercury Biopharmaceutical Corporation (6932.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Mercury Biopharmaceutical Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mercury Biopharmaceutical Corporation (6932.TWO) Average Current Ratio

How has 6932.TWO Current Ratio performed in the past?

The current Current Ratio of Mercury Biopharmaceutical Corporation (6932.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Mercury Biopharmaceutical Corporation (6932.TWO) Current Ratio vs. Peers

How is 6932.TWO’s Current Ratio compared to its peers?

Mercury Biopharmaceutical Corporation’s Current Ratio is less than PhytoHealth Corporation (28.66), greater than Maywufa Company Ltd. (2.92), greater than Johnson Chemical Pharmaceutical Works Co., Ltd. (4.76), greater than Golden Biotechnology Corporation (0.54), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (3.10), less than Anti-Microbial Savior BioteQ Co., Ltd (18.78), greater than Taiwan Bio Therapeutics Co., Ltd (8.15), greater than Intech Biopharm Corporation (1.28), less than TaiRx, Inc. (20.60), greater than InnoPharmax Inc. (6.80),

Build a custom stock screener for Mercury Biopharmaceutical Corporation (6932.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mercury Biopharmaceutical Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mercury Biopharmaceutical Corporation (6932.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mercury Biopharmaceutical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.